Drugs / NITRAMINE
NITRAMINE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05581407 | Oct 2022 → Aug 2023 | influenza | LiteVax BV | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NITRAMINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314967 ↗ |
| Known as | NSC-2166 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314967 ↗ |
| Known as | Picrylmethylnitramine | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314967 ↗ |
| Known as | TETRALITE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05581407 ↗ |
| Known as | Tetryl | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314967 ↗ |
| Modality | Small molecule | — CHEMBL5314967 ↗ |